Background:
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is an inflammatory condition caused by an abnormal response to noxious gases and particles [1] . COPD is associated with considerable global morbidity and mortality and it has been projected to be the fourth highest cause of death by 2030 [2] . Acute exacerbations of COPD are episodes which are characterised by a worsening of respiratory symptoms associated with variable degrees of physiological deterioration [3] . These events are a major cause of morbidity and mortality globally, and COPD exacerbations are a leading cause of hospital admissions [3] .
Lower airway bacterial colonisation (LABC) is a common and important feature of COPD and the commonly isolated organisms are Streptococcus pneumoniae, Haemophilus influenzae
and Moraxella catarrhalis [4, 5] , although most studies investigating LABC have used culture techniques. LABC has been shown to be related to an increase in airway inflammation, exacerbation frequency and lung function decline [5] [6] [7] [8] .
Previous studies suggest that the majority of exacerbations have an infectious aetiologywith approximately half of these events associated with culture of potentially pathogenic airway bacteria, similar to those found in the stable state [9] . Positive cultures of Pseudomonas aeruginosa have also been shown to be associated with COPD but more commonly in advanced disease [10] .
To date, the vast majority of analysis of bacterial prevalence and load has been based on culture but there is little on PCR comparison with culture. The use of culture-independent techniques such as quantitative PCR (qPCR) has not been extensively studied in the context of atypical airway bacteria, which are characteristically difficult to culture (Chlamydophila pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae) with one previous study showing no association with COPD exacerbations [11] . Conversely, serological analysis has suggested an association [12, 13] and further examination is warranted.
The objective of this study was to investigate the prevalence and load of typical and atypical airway bacteria in COPD using modern molecular techniques. We also analysed prevalence and load at the stable and exacerbation states, and compared qPCR with routine microbiological culture.
METHODS

Recruitment criteria
This study involved 134 subjects enrolled in the London COPD cohort between January 2007 and March 2011. The patients form part of a rolling cohort used to prospectively investigate the mechanisms and aetiology of COPD exacerbations, as previously described by our group [14] . Patients were included if the forced expiratory volume in one second (FEV 1 ) was ≤80% predicted and FEV 1 /forced vital capacity (FVC) ratio was <0.7, in keeping with GOLD stages II-IV [1] . A history of chronic symptoms (dyspnoea, sputum production, wheeze and cough) was taken, as well as smoking history (number of pack-years smoked, current smoking status). Patients with a history of any other significant respiratory diseases were excluded, as were those unable to complete daily diary cards.
Definitions of Clinical States
An exacerbation was defined as new or increased respiratory symptoms for two or more consecutive days, with at least one major symptom (dyspnoea, sputum purulence and sputum volume) and another major or a minor symptom (wheeze, cold, sore throat and cough), the first day of which was defined as the day of onset of the exacerbation. Stable state was defined as no symptom-defined exacerbations for the preceding four weeks and the subsequent two weeks post-clinic visit.
Clinical assessment
Spirometry was performed in accordance with ATS/ERS guidelines, using a volumetric storage spirometer (Vitalograph 2160, Maids. Moreton, Buckingham, UK). FEV 1 was expressed as a percentage of that predicted from age, height and sex. Serum C-reactive protein (CRP) quantification was performed to assess systemic inflammation, using Modular Analytics E 170 Module (Roche, burgess Hill, UK). Patients recorded inhaled corticosteroid dosage and usage daily on diary cards. Due to variations in dosage by different medications, we applied beclomethasone-equivalence dosage correction, as previously performed by our group [15] .
Sputum collection and processing
Sputum was spontaneously expectorated into a sterile pot in the stable state and/or at exacerbation. All exacerbation visits occurred within 7 days of exacerbation symptom onset. Patient samples were used in a number of different analyses ( Figure 1 ).
Following expectoration, sputum plugs were separated from saliva using sterile forceps, with one-third being taken for culture analysis where there was sufficient quantity. The 
Multiplex quantitative PCR detection of bacteria
Real-time multiplex qPCR was performed on S. pneumoniae, H. influenzae and M.
catarrhalis, targeting Spn9802 (gene fragment); Haemophilus influenzae P4 lipoprotein gene; and copB outer-membrane-protein gene, respectively. Both Spn9802 [16] and copB 
Statistical analysis
Data were analysed using PASW Statistics v.18 (SPSS Inc., Chicago, USA). The KolmogorovSmirnov test for normality was applied. Clinical data with normal distribution are described in mean (±SD). Differences between groups were analysed by independent-samples t-test, paired-samples t-test, Mann-Whitney U test or one-way ANOVA, dependent upon the sample population being investigated. Relationships between continuous variables were analysed using Pearson's or Spearman's correlation in a univariate analysis, or by linear regression in a multivariate analysis. Frequency distribution was explored by χ 2 -analysis. A probability of p<0.05 was considered to be statistically significant.
Ethical Considerations
The study was approved by the Royal Free Research Ethics Committee and all patients gave informed written consent.
RESULTS
Patient characteristics
Sputum samples from 134 COPD patients were examined. There were no clinically or statistically important differences in stable state clinical characteristics between the subgroups (Table 1) . Figure 3B ).
The species detected with highest prevalence was H. influenzae at stable state (11/52, 21.2%), with S. pneumoniae most frequently seen at exacerbation (13/52, 25%) ( Figure 3A ).
M. catarrhalis showed a significant increase in prevalence at exacerbation (10/52, 19.2%), increasing from 2/52 (3.8%) at the stable state (p=0.014). S. pneumoniae prevalence was significantly higher at exacerbation (13/52, 25.0%) than during stable state (3/52, 5.8%) (p=0.002).
Comparison of Quantitative PCR with culture for the detection of typical bacteria
Culture and qPCR for typical bacteria were compared in 177 samples (105 stable and 72 exacerbation samples) from 74 patients.
Quantitative PCR was far more discriminatory at detecting typical bacteria than culture 
Effect of typical bacteria on lung function in stable state and at exacerbation
Higher bacterial load was significantly correlated to disease severity in the stable state (FEV 1 %predicted); r=-0.299; p=0.033 ( Figure 5) . In a multivariate analysis, the relationship between FEV 1 and airway bacterial load remains significant after allowance of either age (p=0.036) or smoking status (p=0.046), although it just misses statistical significance when both age and smoking status are included in the model (p=0.057).
Percentage (±SD) change in FEV 1 (from stable state) with H. influenzae-associated exacerbations (n=10) was -17.4% (±15.8%), and in exacerbations which had no H. influenzae presence (n=47), the change was -5.9% (±20.0%). This difference was not statistically significant (p=0.09).
Airway bacterial load association with inhaled corticosteroid usage
Forty-seven (92.2%) patients who had bacteria detected in the stable state had inhaled corticosteroid usage recorded: Median (IQR) beclomethasone-equivalent dosage was 2000 (640-2000) µg daily. In a univariate analysis, higher airway bacterial load was also significantly correlated to higher inhaled corticosteroid dosage (corrected for beclomethasone equivalence); r=0.382; p=0.008. This relationship remains significant in a multivariate analysis including age, smoking status and FEV 1 % predicted (p=0.022). and for the M. pneumoniae sample it was 10 7.42 cfu/ml.
Systemic inflammation is related to airway bacterial presence during exacerbations
DISCUSSION
This is the largest study to date to use molecular techniques for detection of airway bacteria and also the first to complimentarily evaluate typical and atypical bacteria in a wellcharacterised cohort of COPD patients. We have explored the relationship between airway bacterial prevalence and load in stable COPD patients and at exacerbations. At exacerbation there is a marked increase in bacterial load in colonised patients, with an absolute increase in the region of 20-fold being identified in positive samples. We have conclusively demonstrated that qPCR is more discriminatory than culture at detecting typical airway bacteria. The role of atypical pathogens in COPD is minor, having been detected at low prevalence and load in very few samples.
We have found that in the stable state, there is a total prevalence rate for the three typical bacteria analysed together of 44.2%. H. influenzae was the most prevalent species identified. H. influenzae is also the most prevalent species in culture based studies [4, 20] .
The prevalence rate using qPCR in this study is higher than prevalence in such culture studies. This work also highlights the association of airway bacteria with a poorer disease outcome in COPD and our previous findings that increased airways inflammation may relate to airway bacterial colonisation [5] and is associated with faster FEV 1 decline [8] . In the stable state, we found significant correlation between higher bacterial load and more severe airflow limitation, independent of age or smoking status.
One previous study compared detection frequency of typical airway bacteria by qPCR and routine microbiological culture in COPD patients, evaluating 30 samples [21] . In a larger dataset, we have now confirmed that qPCR is significantly more discriminatory than culture at detecting each of these three main airway bacteria. It is known that H. influenzae is able to persist intracellularly in the respiratory tract, with possible resultant culture-negative sputum [22, 23] . There were some instances in this study where a sample was culturepositive and PCR-negative and there are a number of potential explanations for this, including technical issues with the primer targets, operator error, or sampling, although the rates of such culture-positive PCR-negative samples were actually very low in our study.
Quantitative PCR is therefore the most appropriate method to determine bacterial prevalence and load, with little additional sensitivity to be gained from running both methods in tandem.
The advantage of qPCR is that it gives a higher rate of detection than culture. Using this technique, this study demonstrates that exacerbations in COPD are characteristically associated with both increased prevalence and load of typical bacteria. This confirms previous data suggesting that the increase in load and acquisition of bacteria seen at exacerbation is driving such exacerbations [24] . Microbiological culture is however useful in other aspects of bacteriology, such as in the identification of antibiotic resistance and so
should not be wholly discounted. One limitation of PCR microbiological technique is that they can detect both viable and non-viable bacteria, while culture detects viable bacteria alone. However, to our knowledge, no studies have shown non-viable bacteria to be present at levels of 10 4 cfu/ml (the lower limit of detection for our PCR assays). Alveolar macrophages are responsible for clearance of DNA from the lungs, and so it is unlikely that DNA from lysed cells would persist for long periods.
It has also been previously demonstrated that airway bacterial presence is associated with increases in inflammatory cytokines [7, 25, 26] . We have found that bacterial presence at exacerbation detected by PCR is significantly associated with higher systemic inflammation using serum CRP. We also found a trend to increased fall in FEV 1 with HI-associated exacerbations, probably due to increased airway inflammation, and this is consistent with our previous data [24] . Many exacerbations of COPD also have a viral aetiology and prior studies have demonstrated that exacerbations involving co-infection with bacteria and viruses are associated with a more impaired lung function [24, 27] .
We also conclusively quantified typical airway bacteria in a cohort of COPD patients, with a concomitant illustration of significant increases in prevalence and load of three of the most commonly isolated bacteria seen in such subjects. This provides further support to previous studies which hypothesise that alterations in 'normal' bacterial colonisation may trigger acute exacerbations of COPD [28] . This study has not examined the strain-switching hypothesis previously put forward [29] . However, strain-acquisition is associated with an increase in bacterial load. Further work is needed to explore whether differences in stable and exacerbation loads are related to the same strain or different strains of specific bacterial species.
For the first time, we have also shown a significant relationship between airway bacterial load and inhaled corticosteroid dosage at the time of sampling in stable patients; this effect was independent of age, smoking status and disease severity. Findings from the TORCH and INSPIRE randomised controlled trials have indicated that inhaled corticosteroid use is related to increased frequency of developing pneumonia in COPD patients [30] [31] [32] . Our data suggests that the increase in airway bacterial colonisation may play a part in increasing susceptibility to pneumonia in COPD.
This study was limited to the three most commonly detected organisms and it is probable that other organisms also contribute to the microbiome. However, recent detailed studies in small numbers of subjects have identified only the presence of commensals in addition to the common bacteria we studied and it is unlikely that other bacteria are playing a significant role [28, 33, 34] . Pseudomonas aeruginosa was not studied in this analysis as its culture detection rate is very low in the London COPD cohort (<1%). Further work is needed to explore whether differences in stable and exacerbation loads are related to the same strain or different strains of specific bacterial species. It is also difficult to differentiate between those strains that were infective and those which were colonising, due to the fact that colonising strains are very likely to also appear at exacerbation. The different methodological approaches required are beyond the scope of this study.
The potential role of atypical bacteria in COPD was important to investigate with qPCR as they are characteristically difficult to culture, and if found at high prevalence or load, could have major implications for therapy. A previous study found little evidence of atypical bacteria colonisation in a qPCR analysis of 248 sputum samples from COPD patients, with just one sample positive for Legionella spp. [11] . The current study investigated the rate of these bacteria in COPD patients and found low prevalence, with one exacerbation sample (1.3%) identified with presence of L. pneumophila. Atypical bacteria are therefore not major pathogens in COPD either in the stable state or at exacerbation, and do not need specific therapy.
This study shows that at COPD exacerbations, airway bacterial prevalence and load increase significantly and are an important aetiological factor driving the event. The presence of increased total bacterial load in the stable state and relationship to disease progression suggests that targeted antibiotic therapy for colonised patients may be beneficial.
Quantitative PCR is more discriminatory than culture, identifying higher airway bacterial prevalence, and thus should have an important role in routine clinical microbiological practice.
Figures: Figure 1 COPD patient groups analysed. Patients may have been in more than one subanalysis. For paired analysis, stable samples were obtained <365 days prior to exacerbation (the nearest stable sample to the exacerbation was used). Association of bacterial load with FEV 1 in stable colonised patients (n=51). This illustrates the association of lower FEV 1 status in patients with higher bacterial loads. Data with FEV 1 % predicted >80% were from patients who had FEV 1 % predicted <80% at recruitment.
